Sonoma Pharmaceuticals Announces The FDA 510k Review Panel Has Rated Its Microdacyn Hydrogel Substantially Equivalent For General & Plastic Surgery On November 8, 2024
Sonoma Pharmaceuticals Announces The FDA 510k Review Panel Has Rated Its Microdacyn Hydrogel Substantially Equivalent For General & Plastic Surgery On November 8, 2024
sonoma醫藥宣佈，FDA 51萬審查小組已經評定其Microdacyn Hydrogel在2024年11月8日對一般和整形外科具有實質等效性
Sonoma Pharmaceuticals Announces The FDA 510k Review Panel Has Rated Its Microdacyn Hydrogel Substantially Equivalent For General & Plastic Surgery On November 8, 2024
sonoma pharmaceuticals宣佈，FDA 51萬審查小組已於2024年11月8日評定其Microdacyn Hydrogel在普通和整形外科方面達到實質等效。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
資訊熱榜
更新時間